20 August 2025

GLP1-RA wins expanded approval for diabetics with CKD

5 minute read

Diabetes Pharmaceuticals

Semaglutide can now be prescribed to treat chronic kidney disease following strong trial results and TGA approval.

This content is for AHPRA registered professionals only.
Login Join Now

End of content

No more pages to load

Email Address

Password

Confirm Password

First Name

Last Name

Full Name LEAVE THIS BLANK

What field do you work in?

Type of University work:

Industry Specialty:

Other:

First Name

Last Name

Address 1

Address 2

City

State

Postal Code

Country

Phone

Card Number

Expiration Date /

Security Code (CVC) (what's this?)

I agree to the Terms and conditions and privacy policy *

Processing...